PharmaCorp Rx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.68	2.24	2.73	0.98
Cash & Short-Term Investments	26.68	2.24	2.73	0.98
Cash Growth	953.69%	-17.99%	178.91%	-
Other Current Assets	-	0.08	-	0.02
Total Current Assets	27.29	2.32	2.73	1
Total Assets	32.08	2.32	2.73	1
Accounts Payable	0.49	0.05	0.02	0.03
Total Current Liabilities	0.64	0.05	0.02	0.03
Total Liabilities	2.01	0.05	0.02	0.03
Common Stock	31.48	2.8	2.74	1
Additional Paid-In Capital	1.12	0.49	0.52	-
Retained Earnings	-2.79	-1.01	-0.54	-0.03
Shareholders' Equity	30.07	2.27	2.72	0.97
Total Liabilities & Equity	32.08	2.32	2.73	1
Net Cash (Debt)	25.69	2.24	2.73	0.98
Net Cash Growth	914.60%	-17.99%	178.91%	-
Net Cash Per Share	0.22	0.11	0.14	0.06
Filing Date Shares Outstanding	116.95	20.28	20	16.17
Total Common Shares Outstanding	116.95	20.28	20	16.17
Working Capital	26.65	2.27	2.72	0.97
Book Value Per Share	0.25	0.11	0.14	0.06
Tangible Book Value	25.94	2.27	2.72	0.97
Tangible Book Value Per Share	0.22	0.11	0.14	0.06

Source: S&P Capital IQ. Standard template. Financial Sources.